| RES | Reticulo-Endothelial System |
|---|---|
| ol | res oleoresin |
| RES | radionuclide esophageal scintigraphy; reticuloendothelial system |
| res | research; resection; resident; residue; resistance |
| AVA | activity vector analysis; antiviral antibody; aortic valve area; aortic valve atresia; arteriovenous... |
| PAP | Pokeweed antiviral protein |
|---|---|
| RES | Reserpine |
| RES | Reticulo Endothelial System |
| RES | <abbreviation> Reticuloendothelial system. (05 Mar 2000) |
|---|---|
| antiviral | <pharmacology> Drugs, including interferon, which stimulate cellular defenses against viruses, reducing cell DNA synthesis and making cells more resistant to viral genes, enhancing cellular immune responses or suppressing their replication. Also refers to genetically engineered drugs that are designed to block viral replication. (14 Nov 1997) |
| antiviral agents | Agents used in the prophylaxis or therapy of virus diseases. They may act to prevent viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; blocking late stages of virus assembly; etc. (12 Dec 1998) |
| antiviral immunity | Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever. (05 Mar 2000) |
| antiviral protein | A human or animal factor, induced by interferon in virus-infected cells, which mediates interferon inhibition of virus replication. (05 Mar 2000) |
| antiviral resistance |
The developed resistance of a virus to specific antiviral therapy.
출처:
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|